Varying Inactive Ingredient Listing On OTC Labeling Requested
This article was originally published in The Tan Sheet
Executive Summary
An across-the-board variance allowing listing possible inactive ingredients on labeling of OTC drugs manufactured by multiple suppliers is requested in a citizen petition filed with FDA May 16. A slightly revised petition followed on May 23.